Rapid Summary
Indian Opinion Analysis
Understanding the molecular basis of biology and its disruption in disease has profound implications for India’s pharmaceutical industry and healthcare sector. Research focused on macromolecular interactions can advance drug revelation efforts within India, bolstering innovation in therapeutic solutions for complex diseases like cancer or autoimmune disorders. Given India’s emerging position as a global hub for pharmaceuticals, investing in cutting-edge biological research could support domestic industries while addressing public health challenges efficiently.